ALK-Abello A/S 0OIR-GB:London Stock Exchange

RT Quote | Exchange | DKK
Last | 4:02 PM GMT
100.80UNCH (UNCH)
52 week range
100.80 - 404.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close149.45
  • 52 Week High404.75
  • 52 Week High Date06/06/13
  • 52 Week Low100.80
  • 52 Week Low Date11/30/22

Key Stats

  • Market Cap3,074.7M
  • Shares Out220.95M
  • 10 Day Average Volume28,903.27
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.16

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close149.45
  • 52 Week High404.75
  • 52 Week High Date06/06/13
  • 52 Week Low100.80
  • 52 Week Low Date11/30/22
  • Market Cap3,074.7M
  • Shares Out220.95M
  • 10 Day Average Volume28,903.27
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.16

RATIOS/PROFITABILITY

  • EPS (TTM)1.52
  • P/E (TTM)66.35
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/16/2017
  • Div Amount5.00
  • Split Date-
  • Split Factor-

Latest On ALK-Abello A/S

 

Profile

MORE
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product...
Lene Skole-Soerensen
Vice Chairman of the Board
Anders Hedegaard
Independent Chairman of the Board
Carsten Hellmann
President, Chief Executive Officer
Soeren Niegel
Executive Vice President - Commercial Operations
Soeren Jelert
Chief Financial Officer, Executive Vice President
Henrik Jacobi M.D.
Executive Vice President - Research and Development
Address
Boege Alle 6-8
Hoersholm
2970
Denmark